Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations

Cefiderocol is a novel siderophore cephalosporin antibacterial with activity against carbapenem-resistant Gram-negative bacteria including Pseudomonas aeruginosa. We report a medically complex patient treated with compassionate use cefiderocol for an empyema caused by extensively drug-resistant P. a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kufel, Wesley D., Steele, Jeffrey M., Riddell, Scott W., Jones, Zachary, Shakeraneh, Pegah, Endy, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300106/
https://www.ncbi.nlm.nih.gov/pubmed/32577400
http://dx.doi.org/10.1016/j.idcr.2020.e00863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300106/
https://www.ncbi.nlm.nih.gov/pubmed/32577400
http://dx.doi.org/10.1016/j.idcr.2020.e00863

Ejemplares similares